$Ptc Therapeutics(PTCT)$ announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has given a negative opinion on Translarna (ataluren) for conversion to full authorization

欧盟给予了完全批准的负面意见，暴跌。